Metrics
- Price
- $116.28
- Market Cap $M
- 779
- Rel Volume
- 0.92
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- -2.30%
- 1D
- -1.10%
- 1W
- +2.05%
- 1M
- -2.47%
- 1M Slope
- -4.14%
- 6M Range
- 147.09%
- Score
- 86.1
- Sharp
- 1.4
Volume
Profile
Monopar Therapeutics is a clinical-stage biopharmaceutical company developing targeted cancer and rare disease therapies, including antibody and small-molecule drug candidates.
Biotech
Pharmaceuticals